J&J prepares to face ruling in first Pinnacle hip implant trial

Johnson & Johnson ($JNJ) is facing allegations that the company, in an effort to preserve billions in profit, ignored overwhelming evidence that its Pinnacle hip implants were dangerous. A Montana woman brought her case to a Dallas, TX, federal court, with closing arguments heard on Oct. 20. She was suing after the device leaked cobalt and chromium material into her bloodstream, causing an infection that required surgical removal. The case brought against the company is the first of more than 6,000 to come regarding the device. A 9-person jury began deliberations yesterday. If found guilty of fraud or acting with malice in its design or handling of the implants, J&J could face a punitive damages judgment. More

Suggested Articles

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.

The dream of a comfortable, tabletop blood testing device, needing only a few drops taken from a finger and a handful of minutes, has now arrived.

Novartis is now teaming up with Amazon’s mammoth cloud computing division to overhaul its manufacturing, supply and business operations.